Tudor Investment Corp
CBIO

Tudor Investment Corp’s Crescent Biopharma CBIO Stock Holding History

Tudor Investment Corp’s Portfolio CBIO Stock Details CBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-165
Closed -$51K – 1431
2020
Q3 		$51K Sell
165
-272
-62% -$104K ﹤0.01% 1214
2020
Q2 		$164K Sell
437
-90
-17% -$25.5K 0.01% 1049
2020
Q1 		$120K Buy
527
+110
+26% +$42K 0.01% 907
2019
Q4 		$220K Buy
417
+82
+24% +$44.4K 0.01% 962
2019
Q3 		$144K Buy
+335
New +$215K 0.01% 980
2016
Q3 		– Sell
-550
Closed -$400K – 1546
2016
Q2 		$400K Buy
+550
New +$379K 0.02% 993

Other funds holding CBIO

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $718M AUM 8.19% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $60.6B AUM 31.35% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return